Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

February 23, 2019

Primary Completion Date

June 25, 2022

Study Completion Date

June 25, 2022

Conditions
Hypovolemia Due to Acute Blood Loss
Interventions
DRUG

Volulyte 6%

Solution for infusion

DRUG

Ionolyte

Solution for infusion

Trial Locations (22)

Unknown

Ziekenhuis Oost-Limburg-ZOL, Genk

Fakultni nemocnice Brno, Brno

Military University Hospital, Prague

CHRU Nancy - Hôpital Central, Nancy

Hôpital de Hautepierre, Strasbourg

Universitätsklinikum Aachen, Aachen

Universitätsklinikum Carl Gustav Carus Dresden, Dresden

Universitätsklinikum Frankfurt, Frankfurt

University Hospital Schleswig-Holstein Campus Kiel, Kiel

Academic Medical Center (AMC) Anesthesiology, Amsterdam

University Medical Center (UMC) Maastricht, Maastricht

Groote Schuur Hospital, Cape Town

Gama Research Centre Emergency Department, Leratong Hospital, Germiston

Gama Research Centre, Germiston

Chris Hani Baragwanath Hospital, Johannesburg

Trident Clinical, Homestead Medical Centre, Kimberley

Steve Biko Academic Hospital, Pretoria

FCRN Clinical Trials Centre, Vereeniging

Clinical Projects Research SA, Worcester

Hospital Universitario Gregorio Marañón, Madrid

Hospital Clinico Universitario, Valencia

Hospital Universitari i Politecnic la Fe, Valencia

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

B. Braun Melsungen AG

INDUSTRY

collaborator

European Society of Anaesthesiology and Intensive Care

OTHER

lead

Fresenius Kabi

INDUSTRY

NCT03338218 - Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients | Biotech Hunter | Biotech Hunter